Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today reported positive early pilot performance data for ViraxImmune™, its blood-based test in development for Long COVID, myalgic ...

A surprisingly easy way to multiply an AI model’s profit is to drive decisions via expected value instead of predictive scores. Here's how, illustrated with fraud detection.

Almost all AAV cases were diagnosed in individuals with high pretest probability, including those with renal disease, peripheral neuropathies, or pulmonary infiltrates. In clinical practice, indirect ...

A locally trained model predicted sepsis early among hospitalized patients, with moderate accuracy, high false-positive rates, and modest lead times that varied with the definition of sepsis used, ...